McMillan Shakespeare Ltd (ASX: MMS) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

McMillan Shakespeare Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $928.57 million
P/E Ratio 769.23
Dividend Yield 2.52%
Shares Outstanding 77.38 million
Earnings per share -0.076
Dividend per share 0.64
Year To Date Return -0.71%
Earnings Yield 0.13%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
11 Mar 2021 $0.3020 100.00% Interim 26 Mar 2021
05 Mar 2020 $0.3400 100.00% Interim 20 Mar 2020
28 Aug 2019 $0.4000 100.00% Final 11 Sep 2019
07 Mar 2019 $0.3400 100.00% Interim 22 Mar 2019
13 Sep 2018 $0.4000 100.00% Final 28 Sep 2018
15 Mar 2018 $0.3300 100.00% Interim 29 Mar 2018
28 Sep 2017 $0.3500 100.00% Final 13 Oct 2017
30 Mar 2017 $0.3100 100.00% Interim 13 Apr 2017
29 Sep 2016 $0.3400 100.00% Final 14 Oct 2016
31 Mar 2016 $0.2900 100.00% Interim 15 Apr 2016
29 Sep 2015 $0.2700 100.00% 16 Oct 2015
30 Mar 2015 $0.2500 100.00% 17 Apr 2015
29 Sep 2014 $0.3100 100.00% 15 Oct 2014
16 Sep 2010 $0.1400 100.00% Final 15 Oct 2010

MMS ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About McMillan Shakespeare Ltd

McMillan Shakespeare Limited (ASX: MMS) is a market leader in salary packaging, novated leasing, and fleet and asset management services. McMillan provides services to major employers across Australia, New Zealand and the United Kingdom through brands including Maxxia, RemServ, Interleasing and Holden Leasing.

Clients include state and federal governments, hospitals, not-for-profit organisations and private corporations.

From its origins in 1988 when McMillan first pioneered Australia’s salary packaging industry, the company has grown into a global organisation and top 200 ASX-listed company. With more than 1,200 staff, offices and representatives in every Australian state and territory, as well as Auckland and London, McMillan manages more than 290,000 employee benefit programs and more than 70,000 vehicles.

The McMillan share price has been impacted in FY20 as the COVID-19 pandemic sent a wrecking ball through Australia’s workforce. However, the professional services firm is gaining traction with its rapid digital program expansion to service customers remotely.

MMS Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
11 Jun 2021 $12.00 $-0.02 -0.17% 343,244 $12.03 $12.20 $11.94
10 Jun 2021 $12.02 $0.00 0.00% 182,221 $11.95 $12.08 $11.85
09 Jun 2021 $12.02 $0.02 0.17% 120,433 $12.21 $12.21 $11.93
08 Jun 2021 $12.00 $0.00 0.00% 193,560 $11.98 $12.06 $11.93
07 Jun 2021 $12.00 $0.00 0.00% 47,881 $12.04 $12.06 $11.93
04 Jun 2021 $12.00 $-0.05 -0.41% 235,459 $12.14 $12.17 $11.92
03 Jun 2021 $12.05 $-0.16 -1.31% 134,488 $11.67 $12.21 $11.67
02 Jun 2021 $12.21 $0.49 4.18% 191,772 $11.73 $12.34 $11.65
01 Jun 2021 $11.72 $0.14 1.21% 59,279 $11.58 $11.72 $11.52
31 May 2021 $11.58 $-0.66 -5.39% 93,540 $12.30 $12.30 $11.57
28 May 2021 $12.24 $0.54 4.62% 425,562 $11.75 $12.24 $11.63
27 May 2021 $11.70 $-0.04 -0.34% 170,866 $11.74 $11.74 $11.44
26 May 2021 $11.74 $0.40 3.53% 130,269 $11.34 $11.77 $11.31
25 May 2021 $11.34 $0.10 0.89% 66,199 $11.24 $11.34 $11.11
24 May 2021 $11.24 $-0.29 -2.52% 155,804 $11.31 $11.36 $11.07
21 May 2021 $11.53 $0.47 4.25% 172,386 $11.11 $11.62 $11.10
20 May 2021 $11.06 $-0.19 -1.69% 75,283 $10.99 $11.23 $10.99
19 May 2021 $11.25 $0.15 1.35% 79,454 $11.05 $11.32 $11.00
18 May 2021 $11.10 $-0.02 -0.18% 167,737 $11.14 $11.16 $11.03
17 May 2021 $11.12 $0.07 0.63% 53,356 $11.24 $11.24 $11.07

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
25 Mar 2021 John Bennetts Sell 40 $450,472
On-market trade.
24 Mar 2021 John Bennetts Sell 57 $639,711
On-market trade.
23 Mar 2021 John Bennetts Sell 11 $126,784
On-market trade.
22 Mar 2021 John Bennetts Sell 28 $320,662
On-market trade.
19 Mar 2021 John Bennetts Sell 11 $137,824
On-market trade.
17 Mar 2021 John Bennetts Sell 25 $280,221
On-market trade.
16 Mar 2021 John Bennetts Sell 45 $508,590
On-market trade.
12 Mar 2021 John Bennetts Sell 6 $76,592
On-market trade.
11 Mar 2021 John Bennetts Sell 50 $603,730
On-market trade.
25 Feb 2021 Kathryn Parsons Buy 2 $25,900
On-market trade.
27 Nov 2020 Michael (Mike) Salisbury Issued 103 $1,221,290
Issue of securities. 191,878 - Indeterminate Rights & Performance Rights.
As per announcement on 30/11/2020.
20 Aug 2020 Kathryn Parsons Buy 4 $42,627
On-market trade.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Timothy Michael Poole Non-Executive DirectorNon-Executive Chairman Dec 2013
Mr Poole is currently Chairman of Aurizon Holdings Limited and a Non-Executive Director of Reece Limited. Mr Poole was previously an executive of the unlisted infrastructure and private equity manager, Hastings Funds Management (1995 to 2007), including being the Managing Director from 2005. He was formerly a Non-Executive Director of Lifestyle Communities Limited, Newcrest Mining Limited and Japara Healthcare Limited. Mr Poole is considered an independent director under the Company's definition of independence.
Mr Bruce John Akhurst Non-Executive Director Apr 2021
Mr Akhurst is an experienced executive and director of ASX listed companies with an understanding of digital, technology, consumer and regulated businesses. Mr Akhurst is currently a Non-Executive Director of Vocus Group Limited, Tabcorp Holdings Limited and Paul Ramsay Holdings, Chair of the Peter McCallum Cancer Foundation and Council Member of RMIT University chairing the Technology and Infrastructure Committee. His executive career has included Executive Chair of Adstream, CEO of Sensis, Group MD and General Counsel of Telstra and Partner of Mallesons Stephen Jaques. Mr Akhurst will chair the People, Culture Committee and be a member of the Risk and Compliance Committee of MMS effect from 1 April 2021.
Mr John G Bennetts Non-Executive Director Dec 2003
Mr Bennetts is an experienced investor and has been the founder and director of many successful Australian companies with businesses in technology, finance and manufacturing. Mr Bennetts is a Non-Executive Director of Sacred Heart Mission and also of Culture is Life. He was a founder of Cellestis Limited and private equity investment firm, Mooroolbark Investments Pty Limited (M-Group). He has also previously provided advisory services to a range of companies in Australia and Asia. Prior to the establishment of the M-Group, he was a Member of the senior executive of the pioneering Australian multinational IT company, Datacraft Limited.
Mr Ross Chessari Non-Executive Director Dec 2003
Mr Chessari is a founder and director of the investment manager, SciVentures Investments Pty Limited (SciVentures). Prior to founding SciVentures, Mr Chessari was the Managing Director of ANZ Asset Management and the General Manager of ANZ Trustees.
Ms Helen Kurincic Non-Executive DirectorNon-Executive Chairman Sep 2018
Ms Kurincic is Non-Executive Chair of Integral Diagnostics Limited, Non-Executive Director of Estia Health Limited and HBF Health Limited. Formerly, Ms Kurincic was the Chief Operating Officer and Director of Genesis Care from its earliest inception, creating and developing the first and largest radiation oncology and cardiology business across Australia. She has also formerly held Board roles across the publicly listed, private, not-for-profit and government sectors as well as being the former CEO of Benetas and Heart Care Victoria. Ms Kurincic is a Fellow of the Australian Institute of Company Directors. Ms Kurincic is considered an independent director under the Company's definition of independence.
Mr Michael (Mike) Neil Salisbury Chief Executive OfficerManaging Director Oct 2014
Mr Salisbury joined MMS as Managing Director of RemServ in April 2008 and was appointed to the position of Chief Executive Officer in October 2014. Before joining the company in April 2008, Mr Salisbury was a Member of the senior management team at AAMI. Mr Salisbury held a management positions within the organisation, including a number of state management roles and the position of Product Manager for Compulsory Third Party Insurance. Mr Salisbury is a Member of the Australian Institute of Company Directors, and is a Director of the National Automotive Leasing & Salary Packaging Association.
Ms Kathryn Parsons Non-Executive Director May 2020
Ms Parsons is a an experienced senior executive and has finance, accounting and risk management experience across a range of industries locally and internationally. Ms Parsons is a former audit partner at Ernst & Young and has spent time as a partner in the firm's US, UK and Australian practices. During the last five years she was part of the firm's Oceania Assurance Leadership team as the Professional Practice Director with responsibility for assurance quality and risk management in the region. She will join as member of the Risk and Compliance Committee of company effective 22/05/2020.
Mr Ashley Conn Chief Financial OfficerCompany Secretary Oct 2020
-
Ashley Conn Chief Financial OfficerCompany Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Tt Investments Pty Ltd 29,006,159 12.56%
HSBC Custody Nominees (Australia) Limited 18,349,447 7.94%
Prudential Nominees Pty Ltd 13,650,000 5.91%
Pentagon Financial Services Pty Limited 13,579,009 5.88%
National Nominees Limited 13,219,218 5.72%
Wyllie Group Pty Ltd 12,474,576 5.40%
J P Morgan Nominees Australia Pty Limited 11,096,604 4.80%
Pentagon Capital Pty Limited 9,456,279 4.09%
Citicorp Nominees Pty Limited 8,077,895 3.49%
Tt Investments Pty Limited 7,236,994 3.13%
UBS Nominees Pty Ltd 7,129,989 3.08%
National Exchange Pty Ltd 6,400,000 2.77%
Pentagon Capital Pty Limited I 4,500,000 1.94%
Mr Glenn Butterworth 3,000,000 1.29%
Mr James Storey 3,000,000 1.29%
Mr Tony Pitt 3,000,000 1.29%
BNP Paribas Noms (Nz) Ltd 1,700,684 0.73%
Gemtrick Pty Ltd 1,250,000 0.54%
Cs Fourth Nominees Pty Limited <Hsbc Cust Nom Au Ltd 11 1,105,043 0.47%
Neweconomy Com Au Nominees Pty Limited 1,066,681 0.46%

Profile

since

Note